Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

RTW Investments LLC

Investor type Hedge Fund


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 72
Average round size
The average size of a deal this fund participated in
Portfolio companies 58
Rounds per year 5.54
Lead investments 12
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 25
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of RTW Investments LLC:
Typical Co-investors
RTW Investments LLC is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after RTW Investments LLC:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
9Unicorns Accelerator Fund India, Maharashtra, Mumbai
Cambridge Technology Partners Nyon, Switzerland, Vaud
Chengdu Culture & Tourism Development Group Chengdu, China, Sichuan
Climate Fund Managers -
Exceed Capital Partners California, San Francisco, United States
IC Global Partners Dubai, United Arab Emirates
JM Molina Investments -
Lotus Lake Ventures Beijing, Beijing, China
National Nuclear Security Administration District of Columbia, United States, Washington
National Talents Al Khobar, Ash Sharqiyah, Saudi Arabia
Nomura Asset Management Japan, Tokyo
NovAtel Alberta, Calgary, Canada
One97 Mobility Fund India, Noida, Uttar Pradesh
Prometheus Group North Carolina, Raleigh, United States
Ruyi Capital China, Shanghai
Scentan Ventures Central, Central Region, Singapore
Siena Capital -
Taiyo Kagaku -
Watsco Ventures Florida, Miami, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

CARGO Therapeutics

$200M01 Mar 2023 Palo Alto, California, United States

Oricell Therapeutics

Health Care
Product Research
$45M28 Feb 2023 Shanghai, Shanghai, China

Apogee Therapeutics

Life Science
$149M07 Dec 2022 San Francisco, California, United States

immatics biotechnologies

$110M10 Oct 2022 Germany, Baden-Württemberg, Germany


Health Care
$150M19 Sep 2022 California, United States


$140M18 Jul 2022 Vale of White Horse, England, United Kingdom

Mineralys Therapeutics

$118M08 Jun 2022 Radnor, Pennsylvania, United States

MoonLake Immunotherapeutics

$115M06 Apr 2022 Zug, Zug, Switzerland

2seventy bio

$170M16 Mar 2022 -
Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders

– Neurogastrx, a privately held specialty pharmaceutical company developing transformative therapies for gastrointestinal (GI) disorders, announced the successful completion of a $60m Series B crossover round led by Vivo Capital.
– Other new investors participating in the Series B round include RTW Investments, Samsara BioCapital and Marshall Wace, joining 5AM Ventures, venBio and OrbiMed Advisors.
– Proceeds from the financing will be used to advance the company’s pipeline of GI therapies for serious conditions that impact millions of people yet are not effectively treated.

Umoja Biopharma Raises $210M in Series B Funding

– Umoja Biopharma is a Seattle, WA-based oncology company.
– The company closed a $210m Series B financing.
– The round was co-led by SoftBank Vision Fund 2 and Cormorant Asset Management with participation from new investors, including RTW Investments, LP; Temasek; Presight Capital (the international venture arm of Christian Angermayer’s Apeiron Investment Group); Caas Capital; and an investment fund associated with SVB Leerink.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent RTW Investments LLC?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: